Literature DB >> 33109059

Robotic Surgery in Inflammatory Bowel Disease.

Jacopo Crippa1, Michele Carvello2, Paulo Gustavo Kotze3, Antonino Spinelli2.   

Abstract

BACKGROUND: Surgery is considered a cornerstone of inflammatory bowel disease (IBD) treatment. In the last years, robotic surgery has seen an increase in adoption rates for both benign and malignant diseases.
OBJECTIVE: This work aims to review the current applications of robotic surgery in IBD. DISCUSSION AND
CONCLUSION: Minimally-invasive techniques have been applied to the treatment of IBD for more than 20 years. Investments in surgical digital and robotic platforms are increasingly arising, with an estimate of getting doubled within the next 5 years. Robotic surgery represents the newest technology available to reduce the impact of surgery on patients affected by IBD, and may theoretically be even more effective than other minimally-invasive techniques given the lower rate of conversion to open surgery as compared to laparoscopy according to many large retrospective series. Data on robotic surgery applied to IBD are still scarce and initial experiences in high-volume centers from retrospective series suggested that robotic surgery may achieve similar results when compared to laparoscopy. A new wave of robotics incorporating artificial intelligence is awaited to empower the capability of IBD surgeon in terms of intraoperative decision-making beyond technical skill enhancement. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Colorectal Surgery; IBD; crohn; minimally invasive surgery; robotic surgery; ulcerative colitis

Year:  2021        PMID: 33109059     DOI: 10.2174/1389450121999200820125918

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  5 in total

Review 1.  Aspects Towards the Anastomotic Healing in Crohn's Disease: Clinical Approach and Current Gaps in Research.

Authors:  F H M Chaim; L M V Negreiros; K M Steigleder; N S N Siqueira; L M Genaro; P S P Oliveira; C A R Martinez; M L S Ayrizono; J J Fagundes; R F Leal
Journal:  Front Surg       Date:  2022-06-24

Review 2.  Artificial intelligence: Emerging player in the diagnosis and treatment of digestive disease.

Authors:  Hai-Yang Chen; Peng Ge; Jia-Yue Liu; Jia-Lin Qu; Fang Bao; Cai-Ming Xu; Hai-Long Chen; Dong Shang; Gui-Xin Zhang
Journal:  World J Gastroenterol       Date:  2022-05-28       Impact factor: 5.374

3.  Mesenchymal stem cells-derived extracellular vesicles containing miR-378a-3p inhibit the occurrence of inflammatory bowel disease by targeting GATA2.

Authors:  Ping Li; Hai-Yan Zhang; Jian-Zhen Gao; Wen-Qiang Du; Dong Tang; Wei Wang; Liu-Hua Wang
Journal:  J Cell Mol Med       Date:  2022-05-17       Impact factor: 5.295

4.  microRNA-15b-5p encapsulated by M2 macrophage-derived extracellular vesicles promotes gastric cancer metastasis by targeting BRMS1 and suppressing DAPK1 transcription.

Authors:  Yi Cao; Yi Tu; Jianbo Xiong; Shengxing Tan; Lianghua Luo; Ahao Wu; Xufeng Shu; Zhigang Jie; Zhengrong Li
Journal:  J Exp Clin Cancer Res       Date:  2022-04-22

5.  The future of robotic surgery for inflammatory bowel diseases.

Authors:  Fahad Gul; Syed Naqash Haider Kazmi; Khawar Abbas; Sajeel Saeed; Jawad Basit
Journal:  Ann Med Surg (Lond)       Date:  2022-08-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.